Practices

The problem

Teams often learn what a stage requires when an investor or a CDMO asks for it.

The cost: the plan is rewritten in a rush, in the weeks that matter most.

Roadmap by company stage

The topics a biotech team usually has to cover at each stage, from discovery to commercial.

  1. Discovery

    Finding and testing candidates in the lab.

    • Lab records and data integrity
    • Biosafety levels for your work
    • Meeting and decision records
    • Sample and reagent tracking

    For heads of research

  2. Preclinical

    Testing a candidate in nonclinical studies.

    • GLP for pivotal safety studies
    • Choosing and overseeing contract labs
    • Early process and analytical method development
    • SOPs and document control

    For lab operations

  3. IND-enabling

    Preparing the data and material needed for a first-in-human trial.

    • GLP toxicology studies
    • The CMC section: manufacture, controls and specifications
    • GMP manufacture of clinical material
    • Pre-IND meeting with FDA
    • IND assembly and submission

    For founders

  4. Phase 1

    First studies in people, usually focused on safety.

    For quality leads

  5. Phase 2

    Studies of dose and early signs of effect.

    For CMC leads

  6. Phase 3

    Larger studies that support a marketing application.

    For CDMO managers

  7. Filing

    Submitting the marketing application.

    • NDA or BLA assembly
    • The CMC section in final form
    • Readiness for pre-approval inspection
    • Electronic records and audit trails

    For regulatory leads

  8. Commercial

    Making and selling the approved product.

    • Commercial GMP manufacture and batch release
    • Post-approval changes and annual reports
    • Continued process verification
    • Supplier and CDMO management
    • Ongoing safety monitoring

Related

Pick your stage, then see the work SI 42 drafts for it.